RecruitingNot applicableNCT06564805

Clinical Trial on the Efficacy of Intralesional Triamcinolone Versus Candida Albicans Antigen in Treating Alopecia Areata

Studying Alopecia

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Universidad Autonoma de Nuevo Leon
Principal Investigator
Fania Muñoz Garza, PhD
Hospital Universitario "Dr. José E. González"
Intervention
Candida Albicans Antigen Injection(drug)
Enrollment
30 enrolled
Eligibility
6 years · All sexes
Timeline
20242025

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06564805 on ClinicalTrials.gov

Other trials for Alopecia

Additional recruiting or active studies for the same condition.

See all trials for Alopecia

← Back to all trials